ArticleFrontiers in oncology2026
Parvovirus B19 infection preceding the diagnosis of childhood myelodysplastic syndrome with low blasts: a case report.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parvovirus B19 (PVB19) infection is a recognized cause of transient bone marrow suppression and pure red cell aplasia; however, pancytopenia with hypocellular marrow and multilineage dysplasia is uncommon in children and poses a diagnostic challenge. We report the case of a previously healthy 7-year-old girl who presented with pancytopenia during acute PVB19 infection, confirmed by high viral loads in peripheral blood, cerebrospinal fluid, and bone marrow. Initial bone marrow examination demonstrated hypocellularity with multilineage dysplasia but did not meet criteria for myelodysplastic syndrome. Comprehensive evaluation excluded autoimmune disease, primary immunodeficiency, inherited bone marrow failure syndromes, and known pediatric MDS predisposition genes. Serial follow-up revealed persistent hypocellularity and evolving dysplasia, ultimately establishing the diagnosis of childhood MDS with low blasts (cMDS-LB). The patient underwent successful allogeneic hematopoietic stem cell transplantation with stable full donor chimerism and hematologic recovery. Post-transplant, she experienced episodes of febrile pneumonitis accompanied by transient increases in PVB19 DNA levels, followed by a gradual decline with persistent low-level PVB19 DNAemia at last follow-up (day +618). This case highlights that PVB19 infection may temporally coincide with, reveal, or contribute to an evolving pediatric myelodysplastic process rather than directly causing it.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.